Rational drug discovery and design require a deep understanding of the structure and thermodynamics of protein–ligand interactions. Here, the human carbonic anhydrase family of enzymes and their specific sulfonamide ligands are used to describe binding assays and crystal structures for understanding of protein–compound recognition principles.